ES448220A1 - Un procedimiento para preparar un compuesto cristalino 6 al-fa, fluoro-11 beta, 21-hihidroxi-16 alfa, 17alfa-zsopropili-dendioxipregna-1,4-dien-3,20-diona. - Google Patents

Un procedimiento para preparar un compuesto cristalino 6 al-fa, fluoro-11 beta, 21-hihidroxi-16 alfa, 17alfa-zsopropili-dendioxipregna-1,4-dien-3,20-diona.

Info

Publication number
ES448220A1
ES448220A1 ES448220A ES448220A ES448220A1 ES 448220 A1 ES448220 A1 ES 448220A1 ES 448220 A ES448220 A ES 448220A ES 448220 A ES448220 A ES 448220A ES 448220 A1 ES448220 A1 ES 448220A1
Authority
ES
Spain
Prior art keywords
flunisolide
respiratory diseases
treat respiratory
compound
polymorphic form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES448220A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES448220A1 publication Critical patent/ES448220A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ES448220A 1975-05-27 1976-05-25 Un procedimiento para preparar un compuesto cristalino 6 al-fa, fluoro-11 beta, 21-hihidroxi-16 alfa, 17alfa-zsopropili-dendioxipregna-1,4-dien-3,20-diona. Expired ES448220A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130075A 1975-05-27 1975-05-27
US58130175A 1975-05-27 1975-05-27

Publications (1)

Publication Number Publication Date
ES448220A1 true ES448220A1 (es) 1977-11-01

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
ES448220A Expired ES448220A1 (es) 1975-05-27 1976-05-25 Un procedimiento para preparar un compuesto cristalino 6 al-fa, fluoro-11 beta, 21-hihidroxi-16 alfa, 17alfa-zsopropili-dendioxipregna-1,4-dien-3,20-diona.

Country Status (15)

Country Link
JP (1) JPS51144719A (enrdf_load_html_response)
AT (1) AT357702B (enrdf_load_html_response)
AU (1) AU506080B2 (enrdf_load_html_response)
CA (1) CA1075228A (enrdf_load_html_response)
DE (2) DE2624924C2 (enrdf_load_html_response)
ES (1) ES448220A1 (enrdf_load_html_response)
FR (1) FR2361900A1 (enrdf_load_html_response)
GB (1) GB1525181A (enrdf_load_html_response)
HK (1) HK8580A (enrdf_load_html_response)
IL (1) IL49652A (enrdf_load_html_response)
MX (1) MX3864E (enrdf_load_html_response)
MY (1) MY8000275A (enrdf_load_html_response)
NL (1) NL191234C (enrdf_load_html_response)
NZ (1) NZ180946A (enrdf_load_html_response)
SE (1) SE421426B (enrdf_load_html_response)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3019250C2 (de) * 1979-05-21 1982-11-11 Syntex Corp., Panama-City Verfahren zur Herstellung einer kristallinen Form von Flunisolid
ATE3774T1 (de) * 1980-05-02 1983-06-15 Schering Corporation Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
KR0132576B1 (ko) * 1988-10-05 1998-04-17 로렌스 티. 웰츠 항-용매 내로의 침전을 통한 미분 고형물 결정 분말의 제조 방법
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
NZ312662A (en) * 1995-06-27 2001-03-30 Boehringer Ingelheim Kg Pharmaceutical aerosol preparations in the form of stable ethanolic solutions of active substances for producing propellant free aerosols
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
DK1555038T3 (da) * 1999-03-03 2011-10-17 Optinose As Nasal administrationsindretning
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
DZ3358A1 (fr) 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2014145067A1 (en) * 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
GB933867A (en) * 1958-12-08 1963-08-14 American Cyanamid Co Fluorinated steroids
US3282791A (en) 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
DE2332663C2 (de) 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
SE421426B (sv) 1981-12-21
JPS51144719A (en) 1976-12-13
AT357702B (de) 1980-07-25
DE2661037C2 (enrdf_load_html_response) 1989-04-06
AU1430176A (en) 1977-12-01
DE2624924C2 (de) 1986-11-27
AU506080B2 (en) 1979-12-13
FR2361900B1 (enrdf_load_html_response) 1979-04-13
NZ180946A (en) 1978-07-28
DE2624924A1 (de) 1977-12-15
CA1075228A (en) 1980-04-08
FR2361900A1 (fr) 1978-03-17
ATA388376A (de) 1979-12-15
NL191234B (nl) 1994-11-01
NL191234C (nl) 1995-04-03
MX3864E (es) 1981-08-26
IL49652A0 (en) 1976-07-30
HK8580A (en) 1980-03-14
SE7605927L (sv) 1976-11-28
GB1525181A (en) 1978-09-20
MY8000275A (en) 1980-12-31
IL49652A (en) 1979-05-31
NL7605699A (nl) 1976-11-30
JPS6247880B2 (enrdf_load_html_response) 1987-10-09

Similar Documents

Publication Publication Date Title
ES448220A1 (es) Un procedimiento para preparar un compuesto cristalino 6 al-fa, fluoro-11 beta, 21-hihidroxi-16 alfa, 17alfa-zsopropili-dendioxipregna-1,4-dien-3,20-diona.
CS184471B3 (en) Treatment of mycelle fungi for the retention of metals by aglomeration
NL180200C (nl) Werkwijze ter bereiding van bolvormige deeltjes van geactiveerde koolstof.
YU19876A (en) Process for obtaining 1,2,3-thiadiazolyl-carbamide
FR2301503A1 (fr) Procede de preparation de 1 alpha, 25-dihydroxycholecalciferol
EG12409A (en) Process for preparing of 1-3,3,3-triarylpropyl-4-phenyl-4-piperidinemethanols compounds used as anti diarrheal
JPS525892A (en) Process for producing waterrsoluble or waterrdistributable polyhydoxyl compounds
IL50140A (en) Apparatus for the treatment of tumors by heatint
JPS565129A (en) Method which use gasifying device by photochemical gassliquid reaction
HU175728B (hu) Sposob poluchenija 13,14-degidro-11-dezoksi-prostagland
JPS5289167A (en) Process for producing fine particular wax
JPS525721A (en) Process for preparing pyrogallol or its salt
GB1485610A (en) Process for the manufacture of cyclohexanediones-1,3
JPS53140895A (en) Irradiator for irradiating to processed matter
IL50046A0 (en) Process for the manufacture of 7,8-epoxy-2-methyloctadecane
HU174155B (hu) Sposob poluchenija 2,4-diamino-5-benzil-pirimidinov
CH611631A5 (en) Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids
CH607988A5 (en) Process for the preparation of 3,5-xylenol
JPS5214997A (en) Method for replacing master cam in cam grinders
JPS5355984A (en) Ion beam irradiating method and its device
HU172951B (hu) Sposob poluchenija farmacevticheskojj kompozicii aktivnojj protiv mastitisa
YU41293B (en) Process for the producing of 3,4-dideoxy-kanamycin b
MW4676A1 (en) Method for the treatment of sugarcance
JPS52658A (en) Process for producing mealy fertilizer
GB1554965A (en) Process for the preparation of 3,17 - dihydroxy - 7 - oxoestra - 1,3,5(10) - triene